NCT00657930View on ClinicalTrials.gov

Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)

CompletedOBSERVATIONAL

Enrollment

2,289

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

observational study - dose and frequency to be prescribed by the physician as a result of standard clinical practice.

Trial Locations (1)

1025

Budapest

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT00657930 - Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir) | Biotech Hunter | Biotech Hunter